Statins: Promising Protective Shield against Doxorubicin Cardiotoxicity-Juniper Publishers

JUNIPER PUBLISHERS-OPEN ACCESS JOURNAL OF CARDIOLOGY & CARDIOVASCULAR THERAPY 


Opinion

Doxorubicin (DOX) as a 40 year-old anthracycline antibiotic is a potent antineoplastic agent extensively used in the treatment of several malignancies [1]. Nevertheless, its clinical application carries the risk of serious non-target tissues toxicities, in particular cardiomyopathy, which manifests as life-threatening congestive heart failure [2]. It has been suggested that several mechanisms including reactive oxygen species over-generation, cardiomyocytes apoptosis, membrane-associated ion pumps dysfunction and topoisomerase II isoforms inhibition may be involved in DOX-induced cardiotoxicity [3-5].

To date, many studies have been carried out using adjunctive therapy to counteract DOX-evoked cardiac damages and it has been proposed that development of alternative cardioprotective strategies for management of DOX-related cardiotoxicity is inevitable [6-8]. However, only few therapeutic regimens have been proven to be useful in clinical practices.

Statins (STNs) as 3-hydroxy-3-methylglutaryl-CoA- reductase inhibitors are first-line cholesterol-lowering agents with pleiotropic biological activities including antioxidant, antiinflammatory, anti-apoptotic and cytoprotective properties [913]. Accordingly, there is a growing body of evidence indicating that STNs as potent cardioprotective agents can protect cardiac tissue against DOX-induced damages along with potentiation of DOX-associated chemotherapies [14-16]. Recently, it has been reported that simvastatin can exert significant cardioprotective effects against DOX-related cardio toxicity through suppression of endoplasmic reticulum stress and activation of Akt signaling and its administration has been suggested as an encouraging approach to manage DOX cardiotoxicity [17].

As a final point, it seems that STNs could serve as safe and promising agents to prevent unfavorable cardiac complications in DOX therapies. Obviously, comprehensive retrospective and prospective clinical trials are needed to confirm the efficacy of STNs in improvement of DOX therapeutic utilities.

For more Open Access Journals in Juniper Publishers please click on: https://juniperpublishers.com

For more Open Access Journals in Juniper Publishers please click on: https://juniperpublishers.com/open-access.php

For more articles in Open Access Journal of Cardiology & Cardiovascular Therapy please click on: https://juniperpublishers.com/jocct/index.php

For more Open Access Journals please click on: https://juniperpublishers.com

To know more about Juniper Publishers please click on: https://juniperpublishers.business.site/

Comments

Post a Comment

Popular posts from this blog

Can We Prevent Cardio Vascular Morbidities and Mortalities?-Juniper Publishers

Image
JUNIPER PUBLISHERS - OPEN ACCESS JOURNAL OF CARDIOLOGY & CARDIOVASCULAR THERAPY   Opinion Cardivan- vascular dieses are group of disease which are totally preventable, it is concluded that almost 90% of CVD is avoidable. Improving risk factors is the key point in Prevention strategies, thus minimizing atherosclerosis process are significantly linked to improving risk factors by: healthy diet consumption, conducting exercises, eliminating tobacco smoke and educing alcohol intake. Lipids and high blood pressure management and control have great impact on CVD morbidities and mortalities. Applying effective strep throat with suitable antibiotics can contribute to decrease risk of rheumatic heart disease. Cardiovascular diseases kept the main cause of mortality worldwide globally. It has been estimated that the mortality rate has been increased from 17.9 million deaths (32.1%) in 2015, up from 12.3 million (25.8%) in 1990 and have been increasing in much of the developi...
Read more

Spinal Cord Injury: An Under Recognized Cardiovascular Disease Risk Factor-Juniper Publishers

Image
JUNIPER PUBLISHERS - OPEN ACCESS JOURNAL OF CARDIOLOGY & CARDIOVASCULAR THERAPY Keywords Keywords: Stroke; Coronary artery disease; Paraplegia; Tetraplegia Opinion Spinal cord injury (SCI) is a devastating, life-changing condition causing paralysis and sensory impairment as well as autonomic dysfunction. In addition, evidence documents a state of chronic inflammation in individuals with SCI [ 1 - 4 ]. Importantly, chronic inflammation is a significant cardiovascular disease risk factor. Furthermore, paralysis can lead to a relatively sedentary life style and a consequent reduction in physical work capacity [ 58 ]. Other consequences of inactivity are a higher body weight, a higher percentage of body fat [ 9 , 10 ], skeletal muscle dysfunction [ 11 - 14 ] and a lower forced vital capacity [ 15 - 17 ]. Autonomic dysfunction involves an abnormal and unstable regulation of the of the heart and vasculature [ 18 ]. ...
Read more